Eventide Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-393,000
| Closed | -$8.02M | – | 138 |
|
|
2016
Q1 | $8.02M | Sell |
393,000
-82,800
| -17% | -$1.69M | 0.45% | 60 |
|
|
2015
Q4 | $24.5M | Sell |
475,800
-4,100
| -0.9% | -$211K | 1.22% | 35 |
|
|
2015
Q3 | $20.5M | Buy |
479,900
+74,600
| +18% | +$3.18M | 1.19% | 32 |
|
|
2015
Q2 | $18.5M | Hold |
405,300
| – | – | 1% | 43 |
|
|
2015
Q1 | $15.4M | Buy |
405,300
+32,900
| +9% | +$1.25M | 1.16% | 38 |
|
|
2014
Q4 | $10.5M | Hold |
372,400
| – | – | 1.15% | 36 |
|
|
2014
Q3 | $9.41M | Hold |
372,400
| – | – | 1.31% | 32 |
|
|
2014
Q2 | $10.9M | Buy |
372,400
+8,900
| +2% | +$260K | 1.48% | 28 |
|
|
2014
Q1 | $9.42M | Buy |
363,500
+190,200
| +110% | +$4.93M | 1.46% | 30 |
|
|
2013
Q4 | $4.46M | Buy |
+173,300
| New | +$4.46M | 1.37% | 38 |
|